These results further support that RBM3 may inhibit osteoblast-induced Wnt/β-catenin activation in PCa cells by inducing CTNNB1 m6A methylation, which in turn reduces mRNA stability as well as the expression level of β-catenin. Here, CTNNB1 is linked to posterior cortical atrophy.